EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access · CC BY 4.0

Inflammation and Insulin Resistance in Diabetic Chronic Coronary Syndrome Patients

Tianyu Li, Peizhi Wang, Xiaozeng Wang iD, Zhenyu Liu, Zheng Zhang, Yongzhen Zhang, Zhifang Wang, Yingqing Feng, Qingsheng Wang, Xiaogang Guo, Xiaofang Tang, Jingjing Xu und 8 weitere

Nutrients · 19.06.2023 · 15 (12) · 2808

DOI: 10.3390/nu15122808 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Nutrients, online erschienen am 19.06.2023. Verfasst von Tianyu Li und 19 weiteren Autor:innen. Beteiligte Einrichtung: National Clinical Research Center for Cardiovascular Diseases, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Ca…. Hauptthemen laut MEDLINE: Insulin Resistance, Acute Coronary Syndrome, Diabetes Mellitus. Die Arbeit wurde bisher 63-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: China National Key R&D Program during the 13th Five-year Plan Period, CAMS Innovation Fund for Medical Sciences, National Clinical Research Center for Cardiovascular Diseases, Fuwai Hospital, Chinese Academy of Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Limited evidence exists on the combined and mediating effects of systemic inflammation on the association between insulin resistance and cardiovascular events in patients with diabetes and chronic coronary syndrome (CCS). This secondary analysis of a multicenter prospective cohort included 4419 diabetic CCS patients. Triglyceride–glucose index (TyG) and high-sensitivity C-reactive protein (hsCRP) were applied to evaluate insulin resistance and systemic inflammation, respectively. The primary endpoint was major adverse cardiac event (MACE). Associations of TyG and hsCRP with cardiovascular events were estimated using Cox regression. A mediation analysis was performed to assess whether hsCRP mediates the relationship between TyG and cardiovascular events. Within a median 2.1-year follow-up period, 405 MACEs occurred. Patients with high levels of TyG and hsCRP experienced the highest MACE risk (hazard ratio = 1.82, 95% confidence interval: 1.24–2.70, p = 0.002) compared to individuals with low levels of both markers. HsCRP significantly mediated 14.37% of the relationship between TyG and MACE (p < 0.001). In diabetic CCS patients, insulin resistance and systemic inflammation synergically increased the risk of cardiovascular events, and systemic inflammation partially mediated the association between insulin resistance and clinical outcomes. Combining TyG and hsCRP can help identify high-risk patients. Controlling inflammation in patients with insulin resistance may bring added benefits.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Insulin ResistanceAcute Coronary SyndromeDiabetes MellitusHumansC-Reactive ProteinProspective StudiesBiomarkersInflammationTriglyceridesBlood GlucoseRisk FactorsGlucoseRisk Assessment

Stichwörter der Autor:innen

cardiac eventchronic coronary syndromediabeteshigh-sensitivity C-reactive proteininflammationinsulin resistancemediation analysistriglyceride–glucose index

Substanzen

C-Reactive ProteinBiomarkersTriglyceridesBlood GlucoseGlucose

Autor:innen und Institutionen

  • National Clinical Research Center for Cardiovascular Diseases, State Key Laboratory of Cardiovascular Disease, Fuwai Hospital, National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking…
  • Cardiovascular Research Institute, Department of Cardiology, General Hospital of Northern Theater Command, Shenyang 110016, China.
  • Department of Cardiology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730, China.
  • Department of Cardiology, The First Hospital of Lanzhou University, Lanzhou 730000, China.
  • Department of Cardiology, Peking University Third Hospital, Beijing 100191, China.
  • Department of Cardiology, Xinxiang Central Hospital, Xinxiang 453002, China.

ORCID-Profile: Xiaozeng Wang, Yaling Han

Förderung

  • China National Key R&D Program during the 13th Five-year Plan Period
  • CAMS Innovation Fund for Medical Sciences
  • National Clinical Research Center for Cardiovascular Diseases, Fuwai Hospital, Chinese Academy of Medical Sciences
  • China National Key R&amp;D Program during the 13th Five-year Plan Period

Zitieren

APA

Li, T., Wang, P., Wang, X., Liu, Z., Zhang, Z., Zhang, Y., Wang, Z., Feng, Y., Wang, Q., Guo, X., Tang, X., Xu, J., Song, Y., Chen, Y., Xu, N., Yao, Y., Liu, R., Zhu, P., Han, Y., & Yuan, J. (2023). Inflammation and Insulin Resistance in Diabetic Chronic Coronary Syndrome Patients. Nutrients, 15(12), 2808. https://doi.org/10.3390/nu15122808

Vancouver

Li T, Wang P, Wang X, Liu Z, Zhang Z, Zhang Y, et al. Inflammation and Insulin Resistance in Diabetic Chronic Coronary Syndrome Patients. Nutrients. 2023;15(12):2808. doi:10.3390/nu15122808

BibTeX
@article{Li2023,
  author = {Li, Tianyu and Wang, Peizhi and Wang, Xiaozeng and Liu, Zhenyu and Zhang, Zheng and Zhang, Yongzhen and Wang, Zhifang and Feng, Yingqing and Wang, Qingsheng and Guo, Xiaogang and Tang, Xiaofang and Xu, Jingjing and Song, Ying and Chen, Yan and Xu, Na and Yao, Yi and Liu, Ru and Zhu, Pei and Han, Yaling and Yuan, Jinqing},
  title = {Inflammation and Insulin Resistance in Diabetic Chronic Coronary Syndrome Patients},
  journal = {Nutrients},
  year = {2023},
  volume = {15},
  number = {12},
  pages = {2808},
  doi = {10.3390/nu15122808}
}
Kostenlos starten →